Herbalife Posts $156M Q4 EBITDA, 6.3% Sales Growth, Guides FY26
Herbalife delivered Q4 adjusted EBITDA of $156 million, surpassing its $144–154 million guidance, with net sales of $1.3 billion, up 6.3% year-over-year. A record $250 million quarter in India and $283 million of debt repaid in 2025 supported leverage reduction to 2.8x and guided 2026 net sales growth of 1-6%.
1. Q4 Financial Results
Herbalife reported Q4 adjusted EBITDA of $156 million, above its guidance range of $144–154 million, with a 12.2% margin, down 20 basis points year-over-year due to foreign exchange headwinds and higher employee bonus accruals. Net sales reached $1.3 billion, up 6.3% year-over-year (5.5% on a constant-currency basis), operating cash flow was $98 million (up 41% YoY), and $30 million of debt was repaid while cash increased by $50 million sequentially.
2. Regional Performance
Results were led by a record $250 million quarter in India, up nearly 15% year-over-year (21% in local currency) following a GST rate cut, while Latin America sales rose 18% reported (11% LC), EMEA sales increased 9% reported (5% LC), Asia Pacific grew 5% reported (9% LC), North America was flat, and China sales declined 4% reported (6% LC) amid an 11% volume drop.
3. Full-Year 2025 Highlights and 2026 Guidance
For full-year 2025, net sales were just over $5 billion, up 1.0% (2.5% ex-FX), adjusted EBITDA was $658 million with a 13.1% margin, operating cash flow totaled $333 million, and $283 million of debt was repaid, reducing leverage to 2.8x. Management issued 2026 guidance for 1–6% net sales growth and $670–710 million of adjusted EBITDA.
4. Pro2col Platform and Ronaldo Investment
The Pro2col digital platform beta expanded across the U.S., Canada and Puerto Rico, aiming to drive personalized distributor engagement through AI tools. Cristiano Ronaldo acquired a 10% stake in HBL Pro2col for $7.5 million and will provide services and sponsorship to boost visibility and adoption.